Sudeep Pharma IPO Date, Price, GMP, Review, Details 2025

The Sudeep Pharma IPO presents an investor with a company that has been providing pharmaceutical, food, and nutrition industry with excipients and specialty ingredients. This summary comprises the business history, revenue trend, financial indicators, and the process of monitoring Sudeep Pharma IPO subscription, Sudeep Pharma IPO GMP, and allotment.

Sudeep Pharma’s IPO opens on November 21, 2025, with a price band of ₹563-₹593 per share. In the grey market, the GMP has surged (16-22%), signaling strong listing expectations. The ₹895 cr issue (fresh + OFS) is being closely watched by investors.

Sudeep Pharma IPO Timeline (Tentative Schedule)

Event	Date
Sudeep Pharma IPO Date (Open)	Friday, November 21, 2025
Sudeep Pharma IPO Date (Close)	Tuesday, November 25, 2025
Tentative Allotment	Wednesday, November 26, 2025
Initiation of Refunds	Thursday, November 27, 2025
Credit of Shares to Demat	Thursday, November 27, 2025
Tentative Listing Date	Friday, November 28, 2025
Cut-off time for UPI Mandate Confirmation	5 PM on Tuesday, November 25, 2025

Sudeep Pharma IPO Details

Detail	Information
Sudeep Pharma IPO Date	November 21, 2025 to November 25, 2025
Listing Date	To be Announced
Face Value	₹1 per share
Issue Price Band	₹563 to ₹593 per share
Lot Size	25 Shares
Total Issue Size	1,50,92,750 shares (aggregating up to ₹895.00 Cr)
Fresh Issue	16,02,024 shares (aggregating up to ₹95.00 Cr)
Offer for Sale (OFS)	1,34,90,726 shares of ₹1 (aggregating up to ₹800.00 Cr)
Issue Type	Bookbuilding IPO
Listing At	BSE, NSE
Share Holding Pre-Issue	11,13,46,602 shares
Share Holding Post-Issue	11,29,48,626 shares

Sudeep Pharma Company & Business Profile

Sudeep Pharma began as a private entity (“Sudeep Pharma Pvt Ltd”), specialising in mineral-based excipients and niche chemical ingredients.

Three manufacturing facilities in Vadodara, Gujarat, with a combined capacity 65,579 MT (as disclosed in DRHP)
Formulations & nutrition companies Customer base Exports 100+ countries.
Business divisions: pharmaceutical ingredients, specialty nutrition and food/feed-grade minerals.

This background forms the foundation of the Sudeep Pharma IPO narrative.

Sudeep Pharma Turnover

Period	Revenue from operations*	Profit after tax*	Growth & Comments
FY-23	₹428.74 crore	₹62.32 crore	Base year for comparison
FY-24	₹459.28 crore	₹133.15 crore	Sharp PAT jump
9-mths ended Dec 2024	₹344.45 crore	₹94.54 crore	Strong growth trending

* Figures approximate, drawn from DRHP.

Turnover improvement and profitability acceleration enhance the business case for the pharma IPO. Investors will assess if this growth is sustainable.

IPO Structure & Use of Proceeds

Important features of the Sudeep Pharma IPO:

Fresh issue of approximately ₹95 crore plus an Offer for Sale (OFS) of around 1.00 crore shares by promoters.
The IPO follows the book-building process with a 35% retail quota, 15% non-institutional quota, and up to 50% allocation for QIBs.
Fresh issue proceeds are planned for capacity expansion, including machinery upgrades at the Vadodara and Nandesari facilities, along with general corporate purposes.

This kind of structure is typical in ingredient-business IPOs.

What Analysts Are Saying About the IPO?

While final valuations are yet to be confirmed, analysts reviewing similar pharma IPOs highlight the following points:

Steady B2B turnover and large customer base reduce business risk.
Exports and niche-ingredient leadership improve margin outlook.
Ingredient companies often fit mid-cap investors seeking stable growth.
Valuation must remain reasonable; if too aggressive, upside may shrink.

Many analysts view a company like Sudeep Pharma positively, but emphasise that valuation and listing-day support will be critical.

Step-by-Step: How to apply for Sudeep Pharma IPO

1. Check eligibility & details

Confirm the Sudeep Pharma IPO dates (Nov 21-25, 2025), price band (₹563-₹593), lot size (25 shares) and cut-off time for UPI mandate (5 PM on Nov 25, 2025).
Ensure that you possess an active Demat account, bank account and UPI ID (when applying to UPI ASBA) or online broker account.

2. Read the RHP/Red Herring Prospectus

Quickly scan business summary, use of proceeds, risk factors and lot size. This helps decide how many lots to bid for.

3. Decide application route

ASBA through bank (Netbanking/Banking app) – most popular among the retail investors.
Broker/Trading app (Zerodha, Upstox, Groww, HDFC Securities, etc.) – a number of brokers offer a single-click IPO application flow.
UPI mandate is usually used for retail ASBA – your bank will block funds until allotment.

4. Calculate how many shares to apply for

Multiply the lot size (25) by the number of lots you want.
Example: 1 lot = 25 shares – at upper band ₹593 – required amount = 25 × 593 = ₹14,825 (blocked via ASBA/UPI).

5. Log in to your chosen platform

On your bank’s netbanking IPO section or on your broker/trading app, find IPO: Sudeep Pharma Pvt Ltd and click Apply.

6. Enter bid details

Choose category: Retail Individual Investor (RII) (if eligible).
Enter the bid price within the band (₹563-₹593) or select “Cut-off” if you want to apply at any price in the band (use with caution).
Enter number of shares (multiples of lot size).

7. Confirm UPI / ASBA mandate

Submit application. You’ll receive a UPI mandate request on your UPI app (PhonePe/Google Pay/Paytm/Bank UPI).
Approve the mandate before the cut-off time (5 PM on Nov 25, 2025) – otherwise the application will fail.

8. Save application acknowledgement

After successful submission you’ll get an Application Reference Number (ARN)/UAN/acknowledgement. Keep a screenshot or note of it.

9. One PAN, one application rule

Do not apply multiple times in the same category with the same PAN – multiple applications can be rejected.

10. Check allotment status

After the allotment date (tentative Nov 26, 2025), check the allotment via: your broker/bank, registrar’s website (e.g., KFin/Link Intime/Chittorgarh), or BSE/NSE IPO allotment pages.

11. Refunds & credit

If not allotted, blocked funds will be released/refunded (initiation tentative Nov 27, 2025).
If allotted, shares are credited to your Demat account (tentative Nov 27, 2025) and the amount blocked is debited.

12. Listing

Shares listed on exchange (BSE/NSE) on tentative listing date (Nov 28, 2025).
You can then view or trade the shares.

Investment Rule of Thumb - Apply for Listing Gains Only if GMP > 20%

For those applying in the Sudeep Pharma Pvt Ltd IPO specifically for listing gains, here is a suggested guideline:

Monitor sudeep pharma IPO GMP on the final open day of the issue.
If GMP > 20%, potential listing gain may exist – consider applying.
If GMP < 20%, skip applying for listing-gain strategy and instead plan to buy in the market post-listing at a better valuation.

This cautious approach ensures you don’t over-pay in a crowded IPO.

Decision Checklist - Should You Apply?

Align the IPO decision with your investment horizon-whether you want short-term listing gains or a medium/long-term position.
Evaluate the Sudeep Pharma turnover trends and the consistency of its margin quality.
Compare the IPO’s implied valuation with listed peers in the pharma and specialty ingredients sector.
Keep an eye on such subscription levels and sudeep pharma IPO GMP on websites such as Chittorgarh.com.
Examine the major risk factors: price fluctuations in raw-materials, concentration of customers and regulatory exposure.
Apply based on your rule-of-thumb for potential listing gain.

Conclusion

The Sudeep Pharma IPO will provide an investor with an opportunity to have a niche but an important part of the pharmaceutical value chain: excipients and specialty ingredients. As its turnover improves, and the company is globalized with reasonably steady business dynamics, medium-term investors are interested in the company due to its stability on the B2B front.

For those chasing listing gains, remember the guideline: apply only if the sudeep pharma IPO GMP on the last day is over 20%. If not, it may be wiser to skip the subscription and plan a market entry after listing at a fairer valuation. Use trusted sources like Chittorgarh.com to monitor subscription, GMP and allotment status.

Also Read : SLBM Full Form: SLBM NSE Mechanism & Best Stock List Guide.